SABR in oligometastatic breast cancer: Current status and future directions

Oligometastatic breast cancer (OMBC) is a heterogeneous disease with intrinsic biological diversity. It is increasingly accepted in clinical practice that patients with OMBC could be treated with the expectation of long-term disease remission. Local ablative treatments, such as radiotherapy or surge...

Descripción completa

Detalles Bibliográficos
Autores principales: Stewart, Rachel, White, Michelle, Tan, Jennifer, Siva, Shankar, Karroum, Lama, David, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579150/
https://www.ncbi.nlm.nih.gov/pubmed/34739890
http://dx.doi.org/10.1016/j.breast.2021.10.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579150/
https://www.ncbi.nlm.nih.gov/pubmed/34739890
http://dx.doi.org/10.1016/j.breast.2021.10.009

Ejemplares similares